Skip to main content
logo
Active Biotech AB (publ) (STO:ACTI)
Sweden flag Sweden · Delayed Price · Currency is SEK
4.000
+0.005 (0.13%)
Nov 2, 2026, 5:29 PM CET

Active Biotech AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
105121116165255276
Market Cap Growth
14.29%4.60%-29.80%-35.20%-7.51%0.37%
Enterprise Value
62113112163204207
Last Close Price
4.004.608.6316.3630.9739.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-103.10103.10103.10103.10103.10
PB Ratio
2.832.183.545.397.385.90
P/TBV Ratio
2.852.193.575.437.445.90

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.030.100.150.180.02
Net Debt / Equity Ratio
-1.18-1.14-0.74-1.03-1.04-1.12
Net Debt / EBITDA Ratio
1.341.760.630.710.621.08
Quick Ratio
4.344.604.143.613.545.49
Current Ratio
4.344.674.403.733.665.64
Return on Equity (ROE)
-140.56%-84.48%-124.26%-140.54%-143.80%-144.87%
Return on Assets (ROA)
-60.37%-41.45%-57.09%-61.13%-67.12%-69.95%
Return on Capital Employed (ROCE)
-91.40%-67.50%-116.20%-138.10%-148.60%-106.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-44.64%-30.78%-33.98%-27.73%-22.91%-18.08%
Buyback Yield / Dilution
-139.90%-220.46%-54.84%-16.21%-9.23%-26.87%